Differentiation of trophoblast cells from human embryonic stem cells: To be or not to be?

65Citations
Citations of this article
118Readers
Mendeley users who have this article in their library.

Abstract

It is imperative to unveil the full range of differentiated cell types into which human pluripotent stem cells (hPSCs) can develop. The need is twofold: it will delimit the therapeutic utility of these stem cells and is necessary to place their position accurately in the developmental hierarchy of lineage potential. Accumulated evidence suggested that hPSC could develop in vitro into an extraembryonic lineage (trophoblast (TB)) that is typically inaccessible to pluripotent embryonic cells during embryogenesis. However, whether these differentiated cells are truly authentic TB has been challenged. In this debate, we present a case for and a case against TB differentiation from hPSCs. By analogy to other differentiation systems, our debate is broadly applicable, as it articulates higher and more challenging standards for judging whether a given cell type has been genuinely produced from hPSC differentiation. © 2014 Society for Reproduction and Fertility.

Cite

CITATION STYLE

APA

Roberts, R. M., Loh, K. M., Amita, M., Bernardo, A. S., Adachi, K., Alexenko, A. P., … Pedersen, R. A. (2014). Differentiation of trophoblast cells from human embryonic stem cells: To be or not to be? Reproduction, 147(5). https://doi.org/10.1530/REP-14-0080

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free